Former Chief Operating Officer · ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Bruce Given

A named executive officer of ARROWHEAD PHARMACEUTICALS in every fiscal year CompBrief holds from FY2016 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$16,343,808

Salary $409,615Stock awards $15,857,500

FY2019: $3,958,759

1st of 8 named executive officers at Arrowhead Pharmaceuticals by FY2020 total.

8 named officers on file for ARROWHEAD PHARMACEUTICALS, FY2020

Bruce Given’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • ARWR’s disclosed peer group of 21 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ARROWHEAD PHARMACEUTICALS’s whole pay program stands against its peers

  • ARROWHEAD PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ARWR→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed January 28, 2021 (DEF 14A).

Free

Get Bruce Given’s full pay file as a PDF — free

More than this page: up to 10 years of Bruce’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Bruce Given compensation by year

ARROWHEAD PHARMACEUTICALS Summary Compensation Table · all 5 fiscal years held
In US dollars, as ARROWHEAD PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020
Salary$415,625$432,250$450,362$488,750$409,615
Bonus$0$0$0$0$0
Stock awards$922,500$589,000$644,000$2,608,200$15,857,500
Option awards$276,575$0$0$0$0
Non-equity incentive$251,796$351,340$445,900$850,000$0
Pension and deferred compensation$0$0$0$0$0
All other$11,399$11,599$11,799$11,799$76,693
Total$1,877,895$1,384,189$1,552,061$3,958,759$16,343,808

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ARROWHEAD PHARMACEUTICALS, INC. DEF 14A filed January 28, 2021, accession 0001193125-21-019640, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ARROWHEAD PHARMACEUTICALS, INC. filed document, accession 0001193125-21-019640. Every figure is read from that document and cited to the page and table it appears in. Filed January 28, 2021.

$1.9M
$1.4M
$1.6M
$4.0M
$16.3M
FY16
FY17
FY18
FY19
FY20
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU250,000$10,765,000—
RSU157,500$6,781,950—
RSU87,500$3,767,750—

Per the Outstanding Equity Awards at Fiscal Year-End table in ARROWHEAD PHARMACEUTICALS, INC.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

ARROWHEAD PHARMACEUTICALS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Bruce Given · this pageFormer Chief Operating Officer$16,343,808
Christopher AnzalonePresident and Chief Executive Officer$14,294,517
James HassardChief Commercial Officer$7,918,296
Javier MartinChief Medical Officer$7,899,071
Curt BradshawFormer Chief Scientific Officer$6,373,206
Kenneth MyszkowskiChief Financial Officer$6,081,852
Patrick O'BrienChief Operating Officer and General Counsel$5,123,502
James HamiltonChief of Discovery and Translational Medicine$3,412,877

The full ARROWHEAD PHARMACEUTICALS compensation record

free company brief

This page is one person within ARROWHEAD PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the ARROWHEAD PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ARROWHEAD PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Bruce Given's compensation dossier · One-time report. No refunds.